BRIDGEWATER, N.J.– Cosette Pharma announced today that it has entered into an agreement with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) to offer CLOMID® (clomiPHENE citrate) 50mg tablets at a low cash price via the Cost Plus Drugs online pharmacy. CLOMID is a proven, prescription fertility medication that has helped millions of women for more than 50 years. It works by stimulating an increase in hormones that support ovulation. It is one of the most widely dispensed prescription fertility medications in the United States.
Cost Plus Drugs launched its online pharmacy in 2022 and was co-founded by investor-entrepreneur Mark Cuban to reduce the cost of prescription medications. It offers the most commonly prescribed drugs at low transparent prices by negotiating prices directly with manufacturers and passing along the savings to consumers. “Everyone should have access to safe, affordable prescription drugs at transparent prices,” commented Cuban at the company’s founding. Several other branded drugs are now available at Cost Plus Drugs. The agreement with Cosette marks the company’s continued expansion into the branded segment of the US pharmaceutical market.
Commenting on the agreement, Cosette Pharma CEO Apurva Saraf stated that “We are excited to offer CLOMID tablets to patients via Cost Plus Drugs. CLOMID is often the first and most affordable step for couples struggling with infertility, and has been proven in clinical studies to have a 30% pregnancy success rate. Access and affordability are top priorities for Cosette, and the partnership with Cost Plus Drugs is an example of our ongoing commitment to patients.”
